دورية أكاديمية
Comparison of the Risk of Recurrent Clostridioides Difficile Infections Among Patients in 2018 Versus 2013.
| العنوان: | Comparison of the Risk of Recurrent Clostridioides Difficile Infections Among Patients in 2018 Versus 2013. |
|---|---|
| المؤلفون: | Guh AY; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Yi SH; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Baggs J; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Winston L; Department of Medicine, University of California San Francisco School of Medicine, San Francisco, California, USA., Parker E; California Emerging Infections Program, Oakland, California, USA., Johnston H; Colorado Department of Public Health and Environment, Denver, Colorado, USA., Basiliere E; Colorado Department of Public Health and Environment, Denver, Colorado, USA., Olson D; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA., Fridkin SK; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Mehta N; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Wilson L; Department of Emergency Health Services, University of Maryland Baltimore County, Baltimore, Maryland, USA., Perlmutter R; Maryland Department of Health, Baltimore, Maryland, USA., Holzbauer SM; Minnesota Department of Health, St. Paul, Minnesota, USA.; Career Epidemiology Field Officer Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., D'Heilly P; Minnesota Department of Health, St. Paul, Minnesota, USA., Phipps EC; New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, New Mexico, USA., Flores KG; New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, New Mexico, USA., Dumyati GK; Department of Medicine, New York Emerging Infections Program and University of Rochester Medical Center, Rochester, New York, USA., Hatwar T; Department of Medicine, New York Emerging Infections Program and University of Rochester Medical Center, Rochester, New York, USA., Pierce R; Oregon Health Authority, Portland, Oregon, USA., Ocampo VLS; Oregon Health Authority, Portland, Oregon, USA., Wilson CD; Tennessee Department of Health, Nashville, Tennessee, USA., Watkins JJ; Tennessee Department of Health, Nashville, Tennessee, USA., Korhonen L; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Paulick A; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Adamczyk M; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gerding DN; Departments of Medicine and Research, Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA., Reddy SC; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. |
| المصدر: | Open forum infectious diseases [Open Forum Infect Dis] 2022 Aug 17; Vol. 9 (9), pp. ofac422. Date of Electronic Publication: 2022 Aug 17 (Print Publication: 2022). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Cary, NC : Published by Oxford University Press on behalf of the Infectious Diseases Society of America, [2014]- |
| مستخلص: | Among persons with an initial Clostridioides difficile infection (CDI) across 10 US sites in 2018 compared with 2013, 18.3% versus 21.1% had ≥1 recurrent CDI (rCDI) within 180 days. We observed a 16% lower adjusted risk of rCDI in 2018 versus 2013 ( P < .0001). (Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.) |
| References: | Lancet Infect Dis. 2012 Apr;12(4):281-9. (PMID: 22321770) Clin Microbiol Infect. 2015 Feb;21(2):164-70. (PMID: 25658560) Antibiotics (Basel). 2022 Jan 30;11(2):. (PMID: 35203786) Clin Microbiol Rev. 2013 Jul;26(3):604-30. (PMID: 23824374) Clin Infect Dis. 2007 Aug 1;45(3):302-7. (PMID: 17599306) PLoS One. 2015 Feb 13;10(2):e0118150. (PMID: 25679978) Open Forum Infect Dis. 2014 Jul 28;1(2):ofu048. (PMID: 25734120) Clin Infect Dis. 2020 Aug 22;71(5):1133-1139. (PMID: 31560051) BMC Infect Dis. 2021 May 19;21(1):456. (PMID: 34016040) N Engl J Med. 2020 Apr 2;382(14):1320-1330. (PMID: 32242357) Clin Infect Dis. 2014 Aug 1;59(3):345-54. (PMID: 24799326) Clin Infect Dis. 2018 Apr 17;66(9):1326-1332. (PMID: 29360950) Clin Infect Dis. 2018 Mar 19;66(7):e1-e48. (PMID: 29462280) PLoS One. 2014 Jun 04;9(6):e98400. (PMID: 24897375) Clin Infect Dis. 2019 Oct 30;69(10):1667-1674. (PMID: 30615074) N Engl J Med. 2017 Jan 26;376(4):305-317. (PMID: 28121498) |
| معلومات مُعتمدة: | TL1 TR002382 United States TR NCATS NIH HHS; UL1 TR002378 United States TR NCATS NIH HHS |
| فهرسة مساهمة: | Keywords: Clostridioides difficile; infection; recurrent |
| تواريخ الأحداث: | Date Created: 20220908 Latest Revision: 20221118 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC9439575 |
| DOI: | 10.1093/ofid/ofac422 |
| PMID: | 36072699 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2328-8957 |
|---|---|
| DOI: | 10.1093/ofid/ofac422 |